GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allegra Medical Technologies Ltd (ASX:AMT) » Definitions » Book Value per Share

Allegra Medical Technologies (ASX:AMT) Book Value per Share : A$-0.01 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Allegra Medical Technologies Book Value per Share?

Allegra Medical Technologies's book value per share for the quarter that ended in Dec. 2023 was A$-0.01.

During the past 12 months, Allegra Medical Technologies's average Book Value Per Share Growth Rate was -208.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Allegra Medical Technologies was 22.50% per year. The lowest was -29.50% per year. And the median was -14.90% per year.

Allegra Medical Technologies's current price is A$0.029. Its book value per share for the quarter that ended in Dec. 2023 was A$-0.01. Hence, today's PB Ratio of Allegra Medical Technologies is .

During the past 13 years, the highest P/B Ratio of Allegra Medical Technologies was 10.15. The lowest was 0.47. And the median was 2.91.


Allegra Medical Technologies Book Value per Share Historical Data

The historical data trend for Allegra Medical Technologies's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allegra Medical Technologies Book Value per Share Chart

Allegra Medical Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.05 0.04 0.02 -0.01

Allegra Medical Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.02 0.01 -0.01 -0.01

Competitive Comparison of Allegra Medical Technologies's Book Value per Share

For the Medical Devices subindustry, Allegra Medical Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allegra Medical Technologies's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allegra Medical Technologies's PB Ratio distribution charts can be found below:

* The bar in red indicates where Allegra Medical Technologies's PB Ratio falls into.



Allegra Medical Technologies Book Value per Share Calculation

Allegra Medical Technologies's Book Value Per Share for the fiscal year that ended in Jun. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-1.50-0.00)/104.46
=-0.01

Allegra Medical Technologies's Book Value Per Share for the quarter that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-1.61-0.00)/119.61
=-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Allegra Medical Technologies  (ASX:AMT) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Allegra Medical Technologies Book Value per Share Related Terms

Thank you for viewing the detailed overview of Allegra Medical Technologies's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Allegra Medical Technologies (ASX:AMT) Business Description

Traded in Other Exchanges
N/A
Address
18-20 Orion Road, Level 8, Lane Cove West, Sydney, NSW, AUS, 2066
Allegra Medical Technologies Ltd is engaged in the research, product development, and manufacturing of medical devices including prosthetic implant tools. It offers adult and adolescent clavicle fixation systems and pins; shoulder implants; hand fracture plates and ulna heads, compression screws, distal radius systems, and hand fracture systems; hip stems and heads, CSF cups, and evolution and resurfacing hip products; and knee replacement systems among others. It operates in two segments Orthopaedics Division, which derives the majority of its revenue sells and distributes its portfolio of medical device products. Innovation Division which invests resources into the development and commercialization of new products to take to market.